ArticleBMC pharmacology & toxicology2015
Availability of medicines in public sector health facilities of two North Indian States.
Article in BMC pharmacology & toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.Applied health economics and health policy · 2021Pooled it
- Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature.Frontiers in public health · 2021Pooled it
- Gaps in access and trust: essential medicine availability, affordability, and barriers to generic medicine use.Public health action · 2026Article
- Public healthcare system preparedness and community perceptions on comprehensive preconception care service delivery in Maharashtra, India.The Indian journal of medical research · 2026Article
- Article
- Local systems, local solutions: which factors drive essential medicine availability in public health facilities across Indonesia?BMJ global health · 2026Article
- Chemotherapy Medications in Sub-Saharan Africa: Availability, Pricing, Affordability, and Predictors of Quality.JCO global oncology · 2026Article
- Pharmacy inventory management practices and constraints in Asia-Pacific hospitals: a systematic review and qualitative synthesis.Journal of pharmaceutical policy and practice · 2026Review
- Access to essential medicines in aspirational districts of India; A multi-site cross sectional study.Journal of family medicine and primary care · 2025Article
- Lassa fever in Bauchi State, Nigeria: communication channels and health-seeking behavior.IJID regions · 2025Article
- Managing medicines in decentralization: discrepancies between national policies and local practices in primary healthcare settings in Indonesia.Health policy and planning · 2025Article
- Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries.BMC cancer · 2024Observational
- Exploring the preferences of traditional versus Western medicine in the Spiti Valley region of India: A qualitative approach.Dialogues in health · 2024Article
- Resource shortage in public health facilities and private pharmacy practices in Odisha, India.Health policy and planning · 2024Article
- Factors Affecting the Availability and Utilization of Essential Medicines in India: A Systematic Review.Journal of pharmacy & bioallied sciences · 2024Review
- Healthcare Cost of Cochlear Implantation in India.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024Article
- Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council.BMC health services research · 2024Article
- The Availability of Essential Antimicrobials in Public and Private Sector Facilities: A Cross-Sectional Survey in a District of North India.Antibiotics (Basel, Switzerland) · 2024Article
- Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross-sectional drugs' dispensaries assessment and patients' perspectives.International journal for equity in health · 2023Article
- An assessment of childhood cancer care services in India - gaps, challenges and the way forward.The Lancet regional health. Southeast Asia · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccess to free essential medicines is a critical component of universal health coverage. However availability of essential medicines is poor in India with more than two-third of the people having limited or no access. This has pushed up private out-of-pocket expenditure due to medicines. The states of Punjab and Haryana are in the process of institutionalizing drug procurement models to provide uninterrupted access to essential medicines free of cost in all public hospitals and health centres. We undertook this study to assess the availability of medicines in public sector health facilities in the 2 states. Secondly, we also ascertained the quality of storage and inventory management systems in health facilities.
methodsThe present study was carried out in 80 public health facilities across 12 districts in Haryana and Punjab states. Overall, within each state 1 MC, 6 DHs, 11 CHCs and 22 PHCs were selected for the study. Drug procurement mechanisms in both the states were studied through document reviews and in-depth interviews with key stakeholders. Stock registers were reviewed to collect data on availability of a basket of essential medicines -92 at Primary Health Centre (PHC) level, 132 at Community Health Centre (CHC) level and 160 at tertiary care (District Hospital/Medical College) level. These essential medicines were selected based on the Essential Medicine List (EML) of the Department of Health (DOH).
resultsOverall availability of medicines was 45.2% and 51.1% in Punjab and Haryana respectively. Availability of anti-hypertensives was around 60% in both the states whereas for anti-diabetics it was 44% and 47% in Punjab and Haryana respectively. Atleast one drug in each of the categories including analgesic/antipyretic, anti-helminthic, anti-spasmodic, anti-emetic, anti-hypertensive and uterotonics were nearly universally available in public sector facilities. On the contrary, medicines such as thrombolytics, anti-cancer and endocrine medicines were available in less than 30% in public sector facilities. Among the medicines which were not available at the time of survey in Haryana, nearly 60% of them were out of stock for 3-6 months whereas 8% of them were out of stock for more than 6 months.
conclusionHealth system needs to be strengthened by making essential medicines available for patients. Ensuring access to free medicines is likely to reduce private expenditure on medicines, which is a long-term, sustainable way to towards universal health coverage in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.